CAS 1875036-75-1

Formule : C25H28N8

InChI : InChI=1S/C25H28N8/c26-14-20-7-4-8-21(13-20)15-27-24-22-23(29-17-30-24)25(31-18-28-22)33-11-9-32(10-12-33)16-19-5-2-1-3-6-19/h1-8,13,17-18H,9-12,14-16,26H2,(H,27,29,30)

Code InChI : DZDNGSNKWIORRZ-UHFFFAOYSA-N

SMILES : C1CN(CCN1CC2=CC=CC=C2)C3=NC=NC4=C3N=CN=C4NCC5=CC=CC(=C5)CN

BI8626

CAS : 1875036-75-1

BI8626

Formule : C₂₅H₂₈N₈

Degré de pureté : ≥98%

Masse moléculaire : 440.54

Ref: 54-BUP04787

N-(3-(Aminomethyl)benzyl)-8-(4-benzylpiperazin-1-yl)pyrimido[5,4-d]pyrimidin-4-amine

CAS : 1875036-75-1

Formule : C₂₅H₂₈N₈

Degré de pureté : 99.84%

Masse moléculaire : 440.5434

Ref: IN-DA023IJP

BI8626

CAS : 1875036-75-1

BI8626 is a ubiquitin ligase inhibitor with protective effects against spontaneous dry syndrome in NOD/ShiLtj mice and inhibits the proliferation of CD4 T cells

Formule : C₂₅H₂₈N₈

Degré de pureté : 99.32%

Couleur et forme : Yellow Viscous

Masse moléculaire : 440.5434

Ref: TM-T14569

BI8626

CAS : 1875036-75-1

BI8626 is a covalent inhibitor of the ubiquitin ligases that are involved in the proteasome pathway. It has been shown to have anti-cancer and anti-inflammatory properties. BI8626 is a small molecule that targets e3 ubiquitin ligases, which are enzymes that regulate protein degradation by ubiquitination. Low expression of these enzymes has been observed in cancer cells and inflammatory diseases. The mechanism of action for BI8626 is not well understood but it is thought that this drug inhibits the proteasome pathway, leading to reduced inflammation and tumor growth.

Formule : C₂₅H₂₈N₈

Degré de pureté : Min. 95%

Masse moléculaire : 440.5 g/mol

Ref: 3D-AAD03675

N-(3-(Aminomethyl)benzyl)-8-(4-benzylpiperazin-1-yl)pyrimido[5,4-d]pyrimidin-4-amine

CAS : 1875036-75-1

Formule : C₂₅H₂₈N₈

Masse moléculaire : 440.56

Ref: ST-EA-CP-P19025